Financial News
Fate Therapeutics, Inc. - Common Stock (NQ:FATE)
1.150
-0.010
(-0.86%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Jul 11, 2025
Add to My Watchlist
Headline News about Fate Therapeutics, Inc. - Common Stock



What 6 Analyst Ratings Have To Say About Fate Therapeutics
January 05, 2023
Via Benzinga


Fate Therapeutics Initiated With Hold Rating - Read Why
July 28, 2022
Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For January 5, 2023
January 05, 2023
Via Benzinga



Benzinga's Top Ratings Upgrades, Downgrades For December 22, 2022
December 22, 2022
Via Benzinga


Benzinga's Top Ratings Upgrades, Downgrades For December 15, 2022
December 15, 2022
Via Benzinga



















Via Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.